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Abstract
Transcriptional regulation by microRNAs (miRNAs) involves complementary base-pairing at target sites on mRNAs, yielding
complex secondary structures. Here we introduce an efficient computational approach and software (FASTH) for genome-
scale prediction of miRNA target sites based on minimizing the free energy of duplex structure. We apply our approach to
identify miRNAtarget sitesin the human and mousetranscriptomes. Ourresults show that shortsequence motifs inthe 59 end
of miRNAs frequently match mRNAs perfectly, not only at validated target sites but additionally at many other, energetically
favourable sites. High-quality matching regions are abundant and occur at similar frequencies in all mRNA regions, not only
the 39UTR. About one-third of potential miRNA target sites are reassigned to different mRNA regions, or gained or lost
altogether, among different transcript isoforms from the same gene. Many potential miRNA target sites predicted in human
are not found in mouse, and vice-versa, but among those that do occur in orthologous human and mouse mRNAs most are
situated in corresponding mRNA regions, i.e. these sites are themselves orthologous. Using a luciferase assay in HEK293 cells,
we validate four of six predicted miRNA-mRNA interactions, with the mRNA level reduced by an average of 73%. We
demonstratethata thermodynamically based computationalapproachto prediction of miRNAbinding sites onmRNAscanbe
scaled to analyse complete mammalian transcriptome datasets. These results confirm and extend the scope of miRNA-
mediated species- and transcript-specific regulation in different cell types, tissues and developmental conditions.
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Introduction
miRNAs are endogenous short (,22 nt) RNAs that exert
regulatory control of many cellular processes, negatively regulating
specific mRNAs via complementary base-pairing at a target site.
miRNAs of plants bind the targeted mRNA with high comple-
mentarity and thereby mark it for degradation, whereas animal
miRNAs more typically bind with sub-optimal complementarity
and inhibit or diminish productive translation [1].
Target sites for complementary base-pairing by miRNAs can be
inferred using computational methods based on empirically deter-
mined features of how known miRNAs bind in vivo to validated target
sites. For example, perfect Watson-Crick (WC) matching over a 6- or
7-nt ‘‘seed’’ region at the 59 end of the miRNA [2–4] is very
important for target recognition and can by itself repress translation
[4]. Base-pairing elsewhere in the miRNA, including at a so-called
T1A site extending the seed region [3] and in the 39 region [3,4], has
also been variously proposed to contribute to target binding.
Although not every validated miRNA-mRNA pair exhibits a short
region of perfect WC complementarity [5–9] and computational
methods based entirely on such seeds will fail to find every likely
target, many experimentally validated target sites exhibit perfect WC
matches in the seed region.
Several distinct algorithmic approaches are utilized to predict
miRNA targets. The most widely used approach is a sequence-
based search, in which a local sequence alignment tool is used to
find target sites with near-perfect WC complementarity to the
query miRNA [10–14]. In this approach, the existence of this seed
region is often assumed. Because miRNA target sites are short and
may exhibit only limited complementarity outside the seed region,
additional criteria based on abstractions of in vivo processes are
then employed to improve the efficiency of the extension step;
these include requiring that targets be conserved across homolo-
gous mRNAs from different species, or requiring multiple matches
by one or more miRNAs. Target sites predicted using this
approach may subsequently be ranked according to hybridization
energy score [12,13], but the actual search is alignment-based.
In a second approach, machine learning [15] and pattern
discovery [9] have been applied to capture features of mRNAs that
are known or suspected to bind mRNAs. This approach builds on
numerous other applications in genomics and bioinformatics, but has
two important limitations. As relatively few miRNA target sites have
been functionally validated, such predictors cannot yet be precise,
and discovery must continually be re-run on the entire database as
new miRNAs are discovered and new binding sites validated.
Further, biologically relevant features that contribute to the
predictions may not be captured or, if captured, may remain
unknown to the user.
Both of the above approaches are complicated by regions of
unpaired nucleotides (loops and bulges) known to be present in
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regions of imperfect pairing in duplexes between the 39 end of a
miRNA and its mRNA target site, sophisticated sequence-based
methods may search for near-perfect WC complementarity in the
seed region (miRNA positions 2–7, 2–8 or 1–7) [11,14] then
extend the search e.g. to the 39 end of the miRNA, rather than
attempting to align the entire miRNA in a single operation.
A third approach [16,17] is based on the perspective that it is
the thermodynamic stability of the RNA-RNA duplex, not its
abstraction as a string-match or model, which allows miRNAs to
bind targets in vivo. Potential target sites are identified as those at
which the free energy of hybridization is minimized; complex
structures involving loops and bulges can readily be accommo-
dated in this calculation. We adopt this third approach in the work
reported here. We introduce the FASTH (FAST Hybridization)
program and, as a first stage, use it to predict potential miRNA-
mRNA interaction sites. The name was chosen to be similar to
FASTA [18] because both programs employ similar search
strategies and both allow bulges (gaps) in the local alignment.
With FASTH, however, we follow a purely biophysical path,
searching for binding targets taking into account (a) RNA base-
pair and base-pair-stacking free energies [19] in perfect helices, (b)
the unfavorable contributions from interior loops and bulges, (c)
energy contributions from single-stranded bases and from
mismatched pairs adjacent to a base pair, and (d) the initiation
energy required to bring the two molecules together and initiate
duplex formation. We assume that the population of duplexes
actually formed between a miRNA and its target region on an
individual mRNA is best represented by the duplex with the
minimum free energy possible, even if this implies the presence of
non-WC base pairs, loops, bulges and/or mismatches.
In many cases, RNA-RNA hybridization results in the
formation of a population of duplexes, one (or a few) with
minimum free energy and many others with increasingly
suboptimal energies. miRNA-mRNA duplexes with slightly
suboptimal free energies probably occur in vivo, perhaps more
transiently or at lower frequencies, and might be biologically
relevant. Finding these suboptimal structures is computationally
expensive, and previous work [16,17] employed dynamic
programming to search the target database. FASTH uses a fast
heuristic (i.e. not dynamic programming) for the database search,
with search time scaling sub-linearly with database size; it can
return a user-specified number (hundreds or thousands) of
suboptimal sites, and process multiple databases with rigorous
minimum free-energy calculations, in a single search.
In the second stage of our approach, we then select those
FASTH results that satisfy empirically derived rules unrelated to
energy minimization per se, including perfect WC complementarity
to the target at the 59 end of miRNAs, minimum numbers of WC
base pairs at the 39 end, and/or specified free energy score
thresholds. As we demonstrate, further criteria can be imposed as
well, capturing features e.g. of the specific mRNA region bound
(59UTR, CDS, or 39 UTR), presence of orthologs in other
transcriptomes, and/or levels of sequence conservation. Energy-
based prediction has recently been extended to include a penalty
term that reflects the free-energy cost associated with disruption of
pre-existing secondary structure at potential target sites on the
mRNA [20–22]; such a term could, if desired, be easily
incorporated into our approach.
With few exceptions, miRNA target-prediction methods have
until now been applied to EST data, focusing on only the 39UTR.
Here we apply our approach to the complete human and mouse
transcriptomes as represented in RefSeq. We parameterized the
second-stage requirements within biologically reasonable ranges,
and observe the effects on number of predicted sites and on
statistical significance. We demonstrate that short strings of
matching nucleotides (usually 6 or 7 in length) appear more
frequently in the 59 end than in the 39 end of human miRNAs. We
show that many energetically favourable binding sites with perfect
seed matches, i.e. potential miRNA targets, occur in all mRNA
regions, and that a substantial number of these sites are reassigned
between mRNA regions depending on the specific transcript
isoform. This opens the possibility that, at least in human,
alternative transcripts of many genomic regions may be differen-
tially regulated by miRNAs. Selected results were thereafter taken
forward into laboratory-based validation. Although the results
reported below focus on results with 313 human miRNAs, very
similar results were also obtained for 233 mouse miRNAs and are
presented in the Supplementary Material S1.
Results
Predicted target sites for an individual miRNA
For each miRNA it is always the case that our approach predicts
a set of targets, distributed through a range of free energy scores.
To assess their quality, we compare them statistically against the
targets predicted, under the same criteria, for a set of control
miRNAs (Figure 1A–E). To this end, for each miRNA we employ
two sets of controls (mononucleotide shuffled, or MS, and first-
order Markov, or FOM) derived to reflect different assumptions,
as described in the Supplementary Text S1; each control miRNA
finds a set of targets, likewise distributed over a range of free
energies. The targets predicted for the real miRNA may be
distributed through better, similar, or worse free energies than are
the targets predicted for its controls. For example, targets
predicted for let-7a are shifted toward better free energies than
are those predicted for both sets of controls (Figure 1B), whereas
targets predicted for miR-17-5p and its controls show similar
energy distributions (Figure 1C). In some cases the true miRNA
found more target sites than did, on average, the corresponding
controls (miR-324-3p, Figure 1D), whereas in other cases each
control, on average, found more targets than did the miRNA
(miR-129, Figure 1E).
Over all these miRNAs, the sets of predicted targets also vary by
free energy score. The targets predicted for some miRNAs (and for
the corresponding controls) show high (poor) energies, with miR-1
among the most extreme in this regard (Figure 1A), whereas better
energies are predicted for others. Panels B, C and D of Figure 1
show the increasingly better energy-score ranges for predicted
targets of let-7a, miR-17-5p and miR-324-3p. The diversity of
these examples with respect to the range (kcal/mol) and shape of
the distribution of energy scores, and number of target sites
predicted with real versus control sequences, reflects an estimate of
the diversity of molecular interactions over the transcriptome. We
return below to the distribution of predicted targets over all human
miRNAs.
For binding sites experimentally validated in human [23], the
actual hybridisation energies returned by FASTH are similar to
those calculated by Tafer and Hofacker using RNAduplex and
RNAplex [17], but are quite different from those computed by
Rehmsmeier et al. using RNAhybrid [16].
Predicted target sites over all human miRNAs
As we have seen, the set of predicted targets for an individual
miRNA can show diversity in number (frequency) and free energy
profile. In Figure 2A–D this case-to-case variation is aggregated
over all sites predicted for the 313 human miRNAs considered in
this study; panels A and C show results with minimal second-stage
miRNA Target Prediction: FASTH
PLoS ONE | www.plosone.org 2 May 2009 | Volume 4 | Issue 5 | e5745Figure 1. Number of predicted miRNA target sites for selected miRNAs in human RefSeq mRNAs distributed through a range of free
energy scores. Numbers of predicted target sites per miRNA and its control sequences for (A) miR-1 and its controls with WC nt 2–8; if miR-1
hybridized with perfect WC complementarity this would yield 230.8 kcal/mol (see Methods); (B) let-7a and imposing only the requirement of WC
base pairs within nucleotide positions 2–8; let-7a perfect WC complementarity would yield 233.2 kcal/mol; (C) miR-17-5p and its controls with WC nt
2–8; perfect WC complementarity would yield 244.5 kcal/mol; (D) miR-324-3p and its controls with WC nt 2–8; perfect WC complementarity would
yield 252.8 kcal/mol; and (E) miR-129 and its controls with WC nt 2–8; perfect WC complementarity would yield 241.4 kcal/mol. Blue bars show
distributions for native miRNAs, red bars for mononucleotide-shuffled controls (MS), and green bars for first-order Markov controls (FOM) (see
Supplementary Text).
doi:10.1371/journal.pone.0005745.g001
miRNA Target Prediction: FASTH
PLoS ONE | www.plosone.org 3 May 2009 | Volume 4 | Issue 5 | e5745filtering (requiring only perfect WC complementarity at nucleotide
positions 2–8), while panels B and D reflect the imposition of an
additional criterion (that there be ,6 mismatches and GU pairs at
positions $15).
In either case, at the lower free energies in aggregate these
miRNAs find more predicted target sites than do control
sequences of the same length and nucleotide composition
(Figure 2A,B). At free energies better than about 215 kcal/mol
the signal-to-noise ratio (S:N, see Methods) remains above 1.5, but
this ratio diminishes rapidly at higher free energies (Figure 2C,D).
At predicted free energies better than about 212 kcal/mol, on
average these miRNAs find more target sites than do the MS
controls. In comparison with the FOM controls, however, the
miRNAs find more target sites only at energies between about
213 and 223 kcal/mol (Figure 2A). The greatest fold difference
reaches 3.33 against the MS controls (albeit for small numbers of
predictions, at 238 kcal/mol) but only 1.51 against the FOM set
(Figure 2C). Similar behaviour is seen for the subset of predictions
that survive more-rigorous second-stage filtering (Figure 2B,D).
Thus at least for miRNA-mRNA binding sites with perfect WC
complementarity in a 7-nt seed region, dinucleotide frequency bias
is a main contributor to stability of the predicted duplex.
The S:N ratio diminishes rapidly at free energies greater (i.e.
worse) than about 215 kcal/mol regardless of whether MS or
FOM controls are used, falling below 1.00 at energies above about
214 and 211 kcal/mol when calculated against the FOM and
MS control sets respectively (Figure 2C). Very similar results are
seen after second-stage filtering (Figure 2D), with S:N falling below
1.00 at energies above about 212 kcal/mol. These results indicate
that an energy-based approach will be increasingly unproductive
as the free energy of duplex formation becomes progressively
weaker beyond a threshold determined, in part, by details of the
second-stage filtering criteria; conversely, ignoring such weak
duplexes should reduce the frequency of false-positive predictions.
Restricting allowable free energies by introduction of a higher
energy threshold improves the overall S:N ratio by around 10–
20% for this set of miRNAs (Supplementary Table S1,
Supplementary Table S2, and Methods).
At energies more-favorable than about 217 kcal/mol, the S:N
ratio either decreases or increases depending on whether the FOM
Figure 2. Number of predicted miRNA target sites and signal-to-noise ratio in human RefSeq mRNAs distributed through a range of
free energy scores. Numbers of predicted target sites (A) imposing only the requirement of WC base pairs within nucleotide positions 2–8; (B)
requiring WC base pairs at positions 2–8, plus ,6 mismatches and GU pairs at position 15 and beyond (see text). For (A) and (B), blue bars show
distributions for native miRNAs, red bars for mononucleotide shuffled (MS) controls, and green bars for first-order Markov (FOM) controls (see
Methods). Signal-to-noise ratio based on MS controls (red bars) and FOM controls (green bars), (C) requiring WC base pairs at nucleotide positions 2–
8 alone, and (D) requiring WC base pairs at positions 2–8, plus ,6 mismatches and GU pairs at position 15 and beyond.
doi:10.1371/journal.pone.0005745.g002
miRNA Target Prediction: FASTH
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suspect that use of FOM underestimates S:N, while use of MS may
overestimate S:N.
Free energies of predicted target duplexes are correlated
with the potential binding energy of each miRNA
Figure 3 shows, over all these 313 human miRNAs, the free
energies of our predicted target duplexes plotted against the
potential binding energy if each miRNA were bound to an ideal
target site with perfect WC complementarity. These miRNAs bind
at their potential target sites within a wide band of energies,
bounded on one side by the energy score at perfect WC base pair
complementarity and on the other by the score associated with the
minimal extent of interaction we consider (e.g. only the seed
regions). The actual predicted free energies are broadly correlated
with the best possible energies but with a wide range of sub-
optimality.
Experimentally validated targets are not restricted to mRNAs
with the energetically most-favorable target sites. For example, five
experimentally validated targets of miR-1 (Figure 1A) have energy
scores between 210.9 and 214.5 kcal/mol (for details see
Table 1). Thus a high (weak) energy score does not by itself
disqualify a predicted site. We are not hypothesizing that true
miRNAs are those that bind most stably, only that stability (unlike
its abstraction as a string) is important in prediction of potential
target sites. Indeed a degree of energetic sub-optimality may be
necessary, where single miRNA has to bind many different target
sites in different mRNAs.
For known miRNAs, occurrence of a 6–7 nucleotide
region of perfect WC base-pairing with mRNAs is biased
toward the 59 end of miRNAs
The minimum sequence complementarity and thermodynamics
of hybridization required for a region of mRNA to serve as a
miRNA target site in vitro are not fully understood. However, many
computational and experimental studies have addressed how
miRNAs recognize and pair with their mRNA target sites
[2,4,10,12–14,24]. One of the most important determinants of
this interaction is the so-called seed region, a stretch of 6 or 7
contiguous nucleotides at or near the 59 end of a miRNA involved
in perfect WC base-pairing with the mRNA [2].
We examined whether our predicted targets possess such a 6–
7 nt region of perfect WC complementarity, and if so, whether it is
preferentially complementary to the 59 end or to the 39 end of the
corresponding miRNA. To compare preferences to the two ends,
we made perfect WC complementarity the second-stage filtering
criterion, and sorted the results into one set of potential targets
with perfect complementarity to the 59 ends of miRNAs, and
another set with perfect complementarity to the 39 ends. As
FASTH identifies targets based only on free energy of hybridiza-
tion, without information about or bias toward any particular
region of the miRNA, our null hypothesis is that all miRNA
regions (including 39 and 59 ends) should show equal numbers of
perfectly complementary target sites. We then did the same using
randomized miRNA sequences as controls (see Methods). We
carried out these experimental and control procedures using four
sets of conditions that represent 6-nt and 7-nt regions of perfect
WC matching, with and without conditions on base-pairing at the
39 end of miRNA and on binding-energy threshold (see legend to
Figure 4 for details).
Figure 4 shows that predicted target sites complementary to the
59 end of the 313 human miRNAs are much more numerous than
those complementary to the 39 end, whereas little or no such
difference is observed with the corresponding MS or FOM
controls. For these miRNAs, the 59 end is favored by a ratio of
1.26–1.52 (depending on second-stage filtering conditions) com-
pared with 0.97–1.03 for the MS and 0.90–1.00 for the FOM
controls (Figure 4A–D).
Figure 5 presents a second perspective on these results. The
number of target sites predicted using known miRNAs, divided by
the number predicted using the randomized controls, can be
considered as a signal-to-noise ratio. In S:N ratio as well as in
number of predicted targets in mRNAs, we observe a clear
preference for perfect WC base pairs involving the 59 end of
miRNAs (Figure 5A–D). The number of high-quality potential
binding sites with a 6–7 nt region of perfect complementarity at
their 59 end (i.e. a seed region) is substantially (1.34–1.87 times)
greater than expected under the null model reflected in the MS
control set, and slightly (1.06–1.33 times) greater than expected
under the null model reflected by FOM. By contrast, the
corresponding ratios for complementarity at the 39 end are
1.04–1.20 and 0.79–0.84 for the MS and FOM control sets
respectively. The ratio of these ratios (1.28–1.55 with MS, 1.26–
1.68 with FOM) describes the selectivity, here favoring the 59 end, at
each filtering condition. Thus motifs with perfect WC comple-
mentarity to a 6–7 nt region at the 59 end of known miRNAs
occur preferentially in mRNAs, relative to motifs complementary
to the 39 end.
For the simplest (although not necessarily biologically mean-
ingful) case considered here, i.e. perfect WC base-pairing of the six
nucleotides constituting positions 2–7 from either the 59 or the 39
end of the (real or randomized) sequences, similar numbers of
target sites are predicted at each end of the MS controls and at the
39 end of real miRNAs (Figure 5A). When positions 2–8 are
considered instead (Figure 5B), only predicted sites at the two ends
of the MS controls remain similar in number; and as second-stage
filtering is made more-stringent by imposing mismatch and free
energy thresholds (Figure 5C–D) the predicted target-site num-
bers, S:N ratios and 59-over-39 selectivity deviate farther. For the
conditions reported in Figure 5A–D, (1) more-stringent filtering
always reduces the number of predicted target sites; (2) except for
39 ends under FOM, more-stringent filtering increases the S:N
ratio; (3) more-stringent filtering tends to increase 59-over-39 end
selectivity; and (4) the FOM controls find more predicted targets
than do the corresponding real miRNAs at 39 ends of mRNA,
resulting in S:N,1.00. We explore some of these parameter
conditions in further detail below.
Exact matching in seed regions does not, of course, tell the
whole story. A high-quality match may not only involve, but also
extend, a seed region. It may also be the case that some sites with
perfect WC complementarity in the seed region show poor overall
free energy scores and consequently are not identified, by our
approach, as potential targets. As demonstrated previously [3],
mismatches (including GU pairs) in the seed region may be
compensated by optimal complementarity elsewhere. In agree-
ment with many previous studies, though, we are able to use the
recognition of a seed region in the 59 end of miRNAs to identity
many energetically favorable candidate mRNA target sites.
Parameters of binding at the 39 end of miRNAs affect the
number and S:N ratios of predicted target sites
We examined the effect of binding parameters at the 39 end of
miRNAs by constraining the total number of mismatches and GU
pairs at nt positions $15 to be ,6 (Figure 6). Except at the
weakest energies this improved the mean S:N ratio, particularly as
calculated against the MS control set (Figure 6C versus D),
although at the cost of a ,50% reduction in number of predicted
miRNA Target Prediction: FASTH
PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5745Figure 3. Calculated free energy of duplex formation at the miRNA target sites predicted by our approach, versus the minimum
possible free energy for that miRNA binding with perfect WC base-pair complementarity to a (theoretical) target site. Free energy
scores of predicted target sites (y-axis) are plotted against the free energy score of each miRNA, where each of 313 human miRNAs binds to a target
site with perfect WC base pair complementary, imposing the requirement(s) of (A) WC base pairs within nucleotide positions 2–8; and (B) WC base
pairs within positions 2–8, plus ,6 mismatches-and-GU pairs at position 15 and beyond (see text for details). The red line is the non-parametric local
fitted line.
doi:10.1371/journal.pone.0005745.g003
miRNA Target Prediction: FASTH
PLoS ONE | www.plosone.org 6 May 2009 | Volume 4 | Issue 5 | e5745Table 1. miRNA targets experimentally validated previously in human from TarBase [23], and our predictions.
Num Validated miR Gene Reference Prediction Predicted miR ID of predicted mRNAs FE UTR/CDS
1 miR-189 SLITRK1 37 * ** hsa-miR-189 NM_052910 217.7 39
2 miR-1 GJA1 38 hsa-miR-1 NM_000165 214.3 39
3 miR-206 GJA1 38 ** hsa-miR-206 NM_000165 218.4 39
4 miR-133 PTBP2 39 hsa-miR-133a NM_021190 218.9 39
5 miR-1 HDAC4 40 hsa-miR-1 NM_006037 214.1 39
5 miR-1 HDAC4 40 hsa-miR-1 NM_006037 213.9 39
6 miR-133 SRF 40 not predicted
7 miR-15a BCL2 28 hsa-miR-15a NM_000633 219.0 39
8 miR-16 BCL2 28 hsa-miR-16 NM_000633 218.9 39
9 miR-223 NFIA 41 * hsa-miR-223 NM_005595 218.6 39
10 miR-221 KIT 42 not predicted
11 miR-222 KIT 42 not predicted
12 miR-10a HOXA1 43 * ** hsa-miR-10a NM_005522 213.9 39
13 miR-130 MAFB 43 not predicted
14 let-7 KRAS 44 not predicted
15 let-7 NRAS 44 not predicted
16 miR-192 SIP1 45 not predicted
17 let-7b LIN28 46 * hsa-let-7b NM_024674 222.0 39
18 let-7e SMC1L1 46 * hsa-let-7e NM_006306 221.7 39
19 miR-141 CLOCK 46 * hsa-miR-141 NM_004898 215.8 39
20 miR-15 DMTF1 46 hsa-miR-15a NM_021145 220.9 39
21 miR-16 CGI-38 46 hsa-miR-16 NM_015964 220.8 39
22 miR-199b LAMC2 46 hsa-miR-199b NM_005562 221.4 39
23 miR-24 MARK14 46 hsa-miR-24 NM_139012 227.1 39
24 miR-24 MARK14 46 hsa-miR-24 NM_139014 227.1 39
24 let-7b MTPN 14 ** hsa-let-7b NM_145808 215.6 39
25 miR-124 MAPK14 14 ** hsa-miR-124a NM_001315 215.8 39
26 miR-124 MTPN 14 not predicted
27 miR-375 ADIPOR2 14 not predicted
28 miR-375 C1QBP 14 not predicted
29 miR-375 JAK2 14 not predicted
30 miR-375 USP1 14 not predicted
31 miR-1 BDNF 11 * hsa-miR-1 NM_001709 214.5 39
31 miR-1 BDNF 11 * hsa-miR-1 NM_170732 214.5 39
31 miR-1 BDNF 11 * hsa-miR-1 NM_170735 214.5 39
31 miR-1 BDNF 11 * hsa-miR-1 NM_170734 214.5 39
31 miR-1 BDNF 11 * hsa-miR-1 NM_170733 214.5 39
31 miR-1 BDNF 11 * hsa-miR-1 NM_170731 214.5 39
32 miR-1 G6PD 11 ** hsa-miR-1 NM_000402 210.8 39
33 miR-101 MYCN 11 ** hsa-miR-101 NM_005378 213.9 39
33 miR-101 MYCN 11 ** hsa-miR-101 NM_005378 213.5 39
34 miR-19a PTEN 11 * predicted in CDS hsa-miR-19a NM_000314 215.6 CDS
35 miR-23 POU4F2 11 ** hsa-miR-19a NM_004575 213.3 39
36 miR-23a CXCL12 11 * predicted in CDS hsa-miR-23a NM_000609 212.5 CDS
37 miR-26a SMAD1 11 ** hsa-miR-26a NM_005900 213.6 39
38 miR-34 DLL1 11 hsa-miR-34a NM_005618 223.2 39
39 miR-34 DLL1 11 hsa-miR-34a NM_005618 215.5 39
39 miR-34 NOTCH1 11 * hsa-miR-34a NM_017617 221.8 39
40 miR-155 AGTR1 47 not predicted
41 miR-21 PTEN 48 not predicted
miRNA Target Prediction: FASTH
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our approach and that were previously validated by others
(Table 1) show .6 (mismatches and GU pairs) beyond nt position
15 (Table 1). Grimson et al. (2007) have likewise reported that
additional WC matching at positions 12–17 (especially 13–16)
enhances miRNA targeting [24].
Other parameters of binding affect the number and
signal:noise ratios of predicted target sites
Identifying the seed as nt positions 2–8 instead of positions 2–7
decreased the number of predicted targets but improved the S:N
ratio of prediction by around 10% (Figure 6A–B). As allowing one
GU pair in the seed region very greatly increased the number of
potential target sites, for each miRNA we ordered our target-site
predictions by free energy score and restricted our examination to
those scoring $40% of the best score observed (Figure 6C). The
results demonstrate that allowing up to one GU pair in the seed
region increases the number of predicted targets (parameter
conditions 1 and 3 above), but decreases the S:N ratio of
prediction; applying more-stringent conditions improves the S:N
ratio; and allowing only a single loop in the middle of the binding
site does not affect the S:N ratio (although many predicted sites
contain such a loop). These results are summarized in Supple-
mentary Table S1.
Energetically favorable binding sites are not restricted to
39UTRs of mRNAs
For short interfering RNAs (siRNAs), whether a target site is
located within a translated region or a non-coding region has only
marginal effects on RNA interference [25]. Plant miRNAs bind
with near-perfect complementarity at sites that are primarily,
though not exclusively, located within the CDS [26]. In animals,
all previously validated miRNA target sites lie in the 39UTR, and
searches are often, although not always [2], restricted to 39UTR
data; modest targeting on CDS has, however, been reported [27].
For this set of known human and mouse miRNAs, however, the
S:N ratios of our predicted binding sites are very similar, regardless
of location in the 59UTR, CDS or 39UTR (Table 2 and Table 3).
Energetically favorable binding sites were more-frequent in the
CDS than in any other region even after normalization by relative
Num Validated miR Gene Reference Prediction Predicted miR ID of predicted mRNAs FE UTR/CDS
42 miR-181 HOXA11 49 hsa-miR-181b NM_005522 218.6 39
42 miR-181 HOXA11 49 hsa-miR-181b NM_153620 218.6 39
42 miR-181 HOXA11 49 hsa-miR-181d NM_005522 217.8 39
42 miR-181 HOXA11 49 hsa-miR-181d NM_153620 217.8 39
43 miR-17-5p E2F1 50 not predicted
44 miR-20 E2F1 50 not predicted
45 miR-375 MTPN 51 not predicted
46 miR-206 FSTL1 52 not predicted
47 miR-206 UTRN 52 not predicted
48 miR-127 BCL6 53 not predicted
49 miR-125a ERBB2 54 * ** hsa-miR-125a NM_001005862 215.5 39
50 miR-125a ERBB3 54 * ** hsa-miR-125a NM_004448 215.5 39
51 miR-27b CYP1B1 55 hsa-miR-27b NM_000104 226.0 39
52 miR-140 HDAC4 56 not predicted
53 miR-106a RB1 57 not predicted
54 miR-20a TGFBR2 57 not predicted
55 miR-26a PLAG1 57 ** hsa-miR-26a NM_002655 214.7 39
56 miR-372 LAST2 58 ** hsa-miR-372 NM_014572 213.1 39
57 miR-373 LAST2 58 ** hsa-miR-373 NM_014572 215.7 39
58 miR-34a E2F3 59 * hsa-miR-34a NM_001949 217.6 39
59 miR-133 ERG 60 predicted in CDS hsa-miR-133a NM_004449 218.8 CDS
59 miR-133 ERG 60 hsa-miR-133a NM_182918 218.8 CDS
60 miR-196 HOXA7 7 not predicted
61 miR-196 HOXC8 7 hsa-miR-196a NM_022658 215.8 39
62 miR-196 HOXD8 7 ** predicted in CDS hsa-miR-196a NM_019558 213.5 CDS
63 miR-1 HAND2 61 * ** hsa-miR-1 NM_021973 210.9 39
64 miR-1 TMSB4X 61 hsa-miR-1 NM_021109 216.9 39
65 miR-21 TPM1 62 not predicted
*not predicted with the second-stage parameter ‘‘under 6 mismatches-and-GU-pairs for nt $15’’.
**not predicted with 40% FE threshold.
doi:10.1371/journal.pone.0005745.t001
Table 1. cont.
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PLoS ONE | www.plosone.org 8 May 2009 | Volume 4 | Issue 5 | e5745size (nt) of region. Predicted sites were slightly under-represented
in 39UTRs relative to mRNA length, perhaps due to their lower
GC content, but show a higher S:N ratio regardless of
parameterization. Thus energetically favorable candidate target
sites may occur in all mRNA regions. Interestingly, a recent report
shows that in mouse, miRNAs regulate cell development through
target sites in CDS regions [28].
Evidence has been presented that for miRNAs with perfectly
WC-complementary 8-nt seed regions, target sites in the 39UTR
are more efficacious in depressing mRNA levels than are sites in
the 59UTR or CDS [24]. Efficacious sites tend to be flanked
,30 nt both upstream and downstream by AU-enriched regions
[24]. Our data confirm that predicted target sites in higher-GC
regions (59UTR and CDS) have lower (more-favorable) energy
scores than our predicted target sites in lower-GC regions
(39UTRs) (Figure 7). Higher-GC regions are expected to contain
more-stably folded local structure, whereas sites in lower-GC
regions may be, on average, more accessible. As a consequence,
miRNAs targeting lower-GC regions may form duplexes at
relatively weaker energies and still be functional, whereas those
targeting the 59UTR or CDS may require more-favorable energies
to compete with pre-existing structure, and this may require
hybridization that extends well beyond the seed region and near
perfect complementary binding to the target sites. An approach
Figure 4. Number of predicted miRNA target sites with perfect WC base-pair complementarity at the 59 end and at the 39 end of
miRNAs in human RefSeq mRNAs. Numbers of predicted target sites and ratios (the number of predicted target sites with perfect WC base pairs
at 59 end divided by the number of predicted target sites with perfect WC base pairs at 39 end) for known miRNAs, and mononucleotide shuffled (MS)
and first-order Markov (FOM) controls (see Methods), with perfect WC base pair complementary at the 59 end (yellow bars) and 39 end (green bars) of
miRNAs, imposing the requirement(s) of (A) WC base pairs within nucleotide positions 2–7; (B) WC base-pairs within positions 2–8; (C) WC base pairs
within positions 2–7. plus ,6 mismatches-and-GU pairs at position 15 and beyond, and 40% free energy threshold; and (D) WC base pairs within
positions 2–8, plus ,6 mismatches and GU pairs at position 15 and beyond, and 40% free energy threshold (see text for details). ‘WC base pairs at 59
end’ indicates the number of target sites when positions are counted from the 59 end of the miRNAs, and ‘WC base pairs at 39 end’ indicates these
values when positions are counted from the 39 end of the miRNAs (i.e. enforcing perfect WC base pairs at the 39 end of miRNAs).
doi:10.1371/journal.pone.0005745.g004
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prominence to target sites in higher-GC regions such as 59UTR or
CDS. Optimizing the prediction of target sites in regions of more-
stably folded local structure (i.e. higher-GC regions) may therefore
require more-strict conditions at the secondary filtering stage.
Individual binding sites are predicted in the coding
region or the UTR, or be absent altogether, depending
on mRNA isoform
As described immediately above, many potential energetically
favorable binding sites can be found in 59UTRs and coding
regions, as well as in the 39UTRs. RefSeq (www.ncbi.nlm.nih.gov/
RefSeq) identifies 2943 protein-coding genes as having more than
one transcriptional isoform in human; these 2943 genes are
represented by 7965 RefSeq mRNAs, among which we predict no
miRNA binding site in any transcript of 64 genes. Removing these
64 genes and their 146 transcripts, we are left with 66381
predicted binding sites distributed across 7819 transcript isoforms
of 2879 multi-transcript human genes. For each of these genes in
turn, we next asked whether a predicted binding site was found in
the same mRNA region in every transcript isoform, reassigned to a
different mRNA region in at least one isoform, or lost altogether in
at least one isoform (Table 4).
Using the parameterization that yields the highest S:N ratio
(Figure 6C), in this set we found 2658 genes (92.3% of 2879) with
7023 isoforms (89.8% of 7819) in which at least one predicted
miRNA target site remains in the same mRNA region in every
isoform; 44972 target sites (67.7% of 66381) thus resist
reassignment or loss across known transcript isoforms. We found
777 genes (27.0%) with 2485 isoforms (31.8%) in which at least
one predicted target site is reassigned to a different mRNA region
Figure 5. Number of predicted miRNA target sites with perfect WC base-pair complementarity at the 59 end and at the 39 end of
miRNAs in human RefSeq mRNAs, and their signal-to-noise ratios. Numbers of predicted target sites and signal-to-noise ratios for known
miRNAs (blue bars) and mononucleotide shuffled and first-order Markov controls (red bars), with perfect WC base pair complementarity at the 59 end
(yellow bars) and 39 end (green bars) of miRNAs, imposing the requirement(s) of (A) WC base pairs within nucleotide positions 2–7; (B) WC base pairs
within positions 2–8; (C) WC base pairs within positions 2–7, plus ,6 mismatches-and-GU pairs at position 15 and beyond, and 40% free energy
threshold; and (D) WC base pairs within positions 2–8, plus ,6 mismatches-and-GU pairs at position 15 and beyond, and 40% free energy threshold
(see text for details). ‘WC base pairs at 59 end’ indicates the number of target sites when positions are counted from the 59 end of the miRNAs, and
‘WC base pairs at 39 end’ indicates these values when positions are counted from the 39 end of the miRNAs (i.e. enforcing perfect WC base pairs at the
39 end of miRNAs).
doi:10.1371/journal.pone.0005745.g005
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targets in this category; most of these cases involve a site found in
the 59UTR of one isoform but in the CDS of a second (e.g. the
energetically most-favorable miR-17-5p target site on TNFSF12
mRNAs: Supplementary Figure S1), or in the CDS of one but in
the 39UTR of a second, although in a small number of isoform sets
a binding site is reassigned among all three regions. Finally, in
2022 genes (70.2%) with 5823 isoforms (74.5%) at least one
predicted target site is lost (or gained) among different isoforms;
14890 target sites (22.4%) are in this category. Clearly, many
genes (thus many sets of transcripts) contain target sites that fall
into more than one of these situations. A proportionally similar
distribution of fates is seen whether the seed region is taken to be
nt 2–7, or nt 2–8 (Table 4).
It is interesting to ask how these frequencies of predicted target-
site reassignment and gain/loss among transcript-isoform sets
compare with the corresponding frequencies for nucleotides
(whether associated with a predicted miRNA target site or not).
Calculation of nucleotide reassignment and gain/loss is straight-
forward for transcript sets with only two isoforms (see Methods),
although more-complicated for larger isoform sets. Of these 2943
genes with multiple isoforms, 1947 have only two isoforms and the
other 996 have three or more (range 3 to 23). Among these 1947,
Figure 6. Effects of other binding parameters. Number of predicted target sites and signal-to-noise ratio of prediction with different seed
lengths: WC base pairs at nucleotide positions 2–7 and 2–8 inclusive, (A) on mononucleotide-shuffled (MS) controls, and (B) on first-order Markov
(FOM) controls. (C) Number of predicted target sites (blue bars) and signal-to-noise ratio (red bars) when different parameters are used, based on MS
controls. Parameter 1: WC base pairs with at most one GU pair within nt 2–7, plus ,6 mismatches and GU pairs at nt $15. Parameter 2: WC base pairs
within nt 2–7, plus ,6 mismatches and GU pairs at nt $15. Parameter 3: WC base pairs with at most one GU pair within nt 2–8, plus ,6 mismatches
and GU pairs at nt $15. Parameter 4: WC base pairs within nt 2–8, plus ,6 mismatches and GU pairs at nt $15. Parameter 5: WC base pairs within nt
2–8, maximum of one loop at nt 9–14, plus ,6 mismatches and GU pairs at nt $15. A 40% free energy threshold was applied in every case.
doi:10.1371/journal.pone.0005745.g006
Table 2. Number of predicted target sites and signal-to-noise
(S:N) ratio in different mRNA regions in human, under four






A miRNA 397673 23302 250028 124343
5.86% 62.87% 31.27%
S:N (MS) 1.34 1.07 1.33 1.43
S:N (FOM) 1.06 1.05 1.05 1.06
DB size 7.21% 56.68% 36.11%
DB GC 52.95% 51.99% 40.46%
B miRNA 175207 10397 113534 51276
5.93% 64.80% 29.27%
S:N (MS) 1.63 1.27 1.62 1.77
S:N (FOM) 1.23 1.19 1.23 1.24
DB size 7.21% 56.68% 36.11%
DB GC 52.95% 51.99% 40.46%
C miRNA 256092 14541 162466 79085
5.68% 63.44% 30.88%
S:N (MS) 1.48 1.18 1.48 1.57
S:N (FOM) 1.15 1.05 1.14 1.19
DB size 7.21% 56.68% 36.11%
DB GC 52.95% 51.99% 40.46%
D miRNA 111981 6476 73147 32358
5.78% 65.32% 28.90%
S:N (MS) 1.87 1.48 1.89 1.93
S:N (FOM) 1.33 1.23 1.33 1.35
DB size 7.21% 56.68% 36.11%
DB GC 52.95% 51.99% 40.46%
Database (DB) size is the proportion of nucleotides in RefSeq mRNA database
(see text). Conditions: A, WC base pairs at nt 2–7; B, WC base pairs at nt 2–7, ,6
mismatches-and-GU-pairs at nt $15, and 40% FE threshold; C, WC base pairs at
nt 2–8; and D, WC base pairs at nt 2–8, ,6 mismatches-and-GU-pairs at nt $15,
and 40% FE threshold.
doi:10.1371/journal.pone.0005745.t002
Table 3. Number of predicted target sites and signal-to-noise
(S:N) ratio in different mRNA regions in mouse, under the







A miRNA 287040 15577 183912 87551
5.43% 64.72% 30.50%
S:N (MS) 1.36 1.08 1.35 1.45
S:N (FOM) 1.12 0.96 1.13 1.13
DB size 6.77% 58.10% 35.13%
DB GC 48.25% 51.35% 39.18%
B miRNA 114035 6326 74562 33147
5.55% 65.39% 29.07%
S:N (MS) 1.68 1.63 1.64 1.78
S:N (FOM) 1.27 1.20 1.27 1.28
DB size 6.77% 58.10% 35.13%
DB GC 48.25% 51.35% 39.18%
C miRNA 187673 9950 121003 56720
5.30% 64.48% 30.22%
S:N (MS) 1.56 1.26 1.55 1.66
S:N (FOM) 1.16 1.01 1.17 1.17
DB size 6.77% 58.10% 35.13%
DB GC 48.25% 51.35% 39.18%
D miRNA 74455 4018 48979 21458
5.40% 65.78% 28.82%
S:N (MS) 1.94 1.56 1.94 2.04
S:N (FOM) 1.34 1.23 1.34 1.36
DB size 6.77% 58.10% 35.13%
DB GC 48.25% 51.35% 39.18%
Database (DB) size is the proportion of nucleotides in RefSeq mRNA database
(see text). Conditions: A, WC base pairs at nt 2–7; B, WC base pairs at nt 2–7, ,6
mismatches-and-GU-pairs at nt $15, and 40% FE threshold; C, WC base pairs at
nt 2–8; and D, WC base pairs at nt 2–8, ,6 mismatches-and-GU-pairs at nt $15,
and 40% FE threshold.
doi:10.1371/journal.pone.0005745.t003
miRNA Target Prediction: FASTH
PLoS ONE | www.plosone.org 12 May 2009 | Volume 4 | Issue 5 | e5745on average 3.4% of nucleotides are reassigned among mRNA
regions, while nucleotide loss averages 9.8% based on the longer
isoform and 18.5% based on the shorter (Supplementary Table
S3). By contrast, for predicted target sites we observe 6.0%
reassignment and 15.2–15.6% gain/loss among transcript sets for
genes with only two isoforms (Table 4). Correction for edge effects
scarcely alters these proportions (Table 4 and Supplementary
Table S3). Thus the observed frequency of target site reassignment
exceeds that expected under a length-proportional model based on
these data, whereas the frequency of gain/loss may not be
significantly different from expectation.
miRNA targets with orthologs in mouse
One motivation for this work has been to predict miRNA target
sites (and thus the mRNAs in which these sites exist) without taking
into account their conservation across different species. However,
most known miRNAs and many validated target sites are
conserved across species, and we can use this information to
improve our prediction accuracy.
Using those 181 pairs of miRNAs orthologous between human
and mouse for which sequence positions 1–8 are identical, we
predicted target sites using two parameterization conditions and
the same sets of randomized human sequences as controls in each
case. Requiring orthology improves the S:N ratio (1.87 compared
to 1.50 for one parameterization, 2.97 compared to 1.81 for the
other against MS controls; 1.81 compared to 1.21 for one
parameterization, 2.61 compared to 1.34 for the other against
FOM) although at the cost of a 72–81% reduction in number of
predicted sites (Table 5).
Under these two conditions, 83–87% of the predicted target
sites present in orthologous mRNAs (human and mouse) occur in
the same mRNA region (e.g. 39UTR); these values are uncorrected
for the few cases in which an mRNA in one species is annotated as
having two or more orthologs in the other. To a first
approximation, miRNA target sites in the same region of
orthologous mRNAs can be considered orthologous sites. Thus
most miRNA target sites present in homologous mRNAs between
human and mouse are themselves orthologous.
miRNA sequences can be highly conserved across different
species, but this does not imply that their target sites are necessarily
similarly conserved in sequence. Under these two parameteriza-
tions, 72–81% of predicted target sites do not have a counterpart
in an orthologous mRNA (Table 5). Many taxon-specific miRNA-
mRNA interactions may be thus available to regulate taxon-
specific developmental processes in human and mouse.
Method evaluation
In our hands, FASTH is about 30-fold faster than RNAhybrid
version 2.1 [16] in finding target sites for a single miRNA among
500 mRNAs (,1.5 Mbp); on a single AMD64 core (1 Gb
Figure 7. Proportion of predicted miRNA target sites (for 313 human miRNAs) as a function of free energy score, in each segment
(59 UTR, CDS and 39 UTR) of human RefSeq mRNAs. Line smoothed for ease of interpretation.
doi:10.1371/journal.pone.0005745.g007
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125 seconds. RNAplex version 1.0.0 is claimed to be 10–27 times
faster than RNAhybrid [17] but could not process even our 500-
mRNA database, as it cannot deal with large sequences
(.,4100 nt) at least on the above-mentioned hardware. Search
time scales linearly with database size for RNAhybrid and
RNAplex, whereas with FASTH it scales sub-linearly (see
Supplementary Text).
We examined the efficiency of our approach in recovering those
miRNA target sites that have been experimentally validated in
human [23] (Table 1) or mouse [9]. Of 82 miRNA binding sites
experimentally validated in human (all of which are in the
39UTR), 65 occur in RefSeq and were available for discovery (see
Methods). Of these we recovered 40 using the most permissive
search criterion (Table 1), i.e. recall was 62%. However, many of
these 40 have poor free energy scores, and about half failed to
meet one or more of the secondary filtering criteria we used to
improve the S:N ratio.
To provide a broader test, we applied the same computational
approach to the RefSeq mouse mRNA database (see Methods),
asking what proportion of the target sites experimentally validated
by Miranda et al. [9] we recovered. As Miranda et al. set different
criteria for target prediction (e.g. allowing GU pairs and a
mismatch in the seed regions) and selected sites for validation on
that basis, not all of their validated sites could have been
discovered by our approach; we correct for this difference, to
Table 4. Numbers of predicted target sites reassigned to a different mRNA region, or gained or lost, among different isoforms of
the same transcriptional region (gene), for the 2943 human protein-coding genes annotated (RefSeq) as having more than one
























A 2–7 None Unique genes 2943 2879 2658 777 2022
1947 1896 1811 409 1213
996 983 847 368 809
Isoforms 7965 7819 7023 2485 5823
3894 3792 3622 818 2426
4071 4027 3401 1667 3397
Target sites 66381 66381 44972 6519 14890
32422 32422 25540 1946 4936
33959 33959 19432 4573 9954
B 2–8 None Unique genes 2943 2783 2435 574 1720
1947 1828 1669 295 1010
996 955 766 279 710
Isoforms 7965 7579 6386 1885 5044
3894 3656 3338 590 2020
4071 3923 3048 1295 3024
Target sites 42690 42690 28717 4251 9722
20726 20726 16334 1252 3240
21964 21964 12383 2999 6582
C 2–7 5 Unique genes 2943 2877 2658 777 2021
Isoforms 7965 7815 7023 2485 5821
Target sites 66271 66271 44908 6511 14852
D 2–7 10 Unique genes 2943 2877 2658 777 2020
Isoforms 7965 7815 7023 2485 5819
Target sites 66166 66166 44831 6501 14834
E 2–8 5 Unique genes 2943 2782 2435 574 1718
Isoforms 7965 7577 6386 1885 5039
Target sites 42629 42629 28683 4243 9703
F 2–8 10 Unique genes 2943 2782 2435 574 1718
Isoforms 7965 7577 6386 1885 5039
Target sites 42557 42557 28622 4243 9692
All defining conditions include ,6 mismatches-and-GU-pairs at nt $15, and 40% FE threshold, but differ by extent of base-paired region, and by correction (or not) for
edge effects. In blocks A–B, the top number in each cell refers to total; the middle number, to genes with exactly two transcriptional isoforms; and the bottom number,
to genes with $3 transcriptional isoforms. ‘‘Target sites remaining in same region’’ means neither reassigned, nor gained or lost, among different isoforms.
doi:10.1371/journal.pone.0005745.t004
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(in [9]) that have GU pairs and/or mismatches in the seed region.
Miranda et al. also give details of their predicted sites that failed
validation (i.e. were false positive predictions); in principle this
makes it possible for us to calculate the sensitivity as well as
specificity of our approach (see Methods). On this basis, our
approach shows high specificity (range 0.50–0.93) but moderate
sensitivity (range 0.33–0.80 depending on miRNA and filtering
criteria) (Table 6). As the number of false positives is small and the
data apply to mouse only, these specificity values should be
interpreted as only indicative for our approach.
Comparison with other methods
We compared our predicted target sites to those identified using
the commonly used methods PicTar [14], TargetScan [11] and
MiRanda [13], restricting our comparison to 39UTR regions of
human mRNAs. Overlap between our predicted target sites and
those of the other methods was 15–19% with PicTar, 13–16%
with TargetScan, and 4–5% with MiRanda depending on the
parameter values used in our second-stage filtering. The overlap
with MiRanda is smaller in part because the number of targets
predicted using MiRanda is smaller (22,896) than with PicTar
(61,820) or TargetScan (44,657) (see Supplementary Table S4).
Pairwise overlaps among the other three methods ranged from 8%
(PicTar vs MiRanda) to 55% (PicTar vs TargetScan) (Supplemen-
tary Table S5). Substantial overlap between predictions of PicTar
and TargetScan has been observed by others [21].
Experimental validation
TheGene Ontology[29] termsmost-enrichedamongourlowest-
energy targets include protein kinase cascade, signalling pathway, negative
regulator of transcription, and anti-apoptosis (Supplementary Table S6).
We selected, for experimental validation, targets to three of
these miRNAs: hsa-miR-17-5p (one target: see below), hsa-miR-
15a (two targets), and hsa-miR-324-3p (three targets). This
selection was made on the basis of functional association with
cancer (hsa-miR-17-5p, hsa-miR-15a) or predicted targets in the
Wnt signalling pathway (hsa-miR-324-3p) as described in
Supplementary Table S7. Sequence corresponding to individual
predicted target sites was cloned into the 39UTR of a luciferase-
expressing vector, and luciferase activity (directly proportional to
translation from the plasmid) was measured in the presence of
either the test miRNA, or a control miRNA-like sequence. For
replication, normalization and statistical analyses see Methods.
For five of the six targets subjected to experimental validation,
expression was inhibited by the corresponding miRNA (Figure 8).
Assessed by p-value, this decrease was significant for the TSPYL2
and WNT9B constructs at 10 and 50 nM, and for the BCL2 and
TNFSF12 constructs at 50 nM. BCL2 mRNA has previously been
validated as a target for has-miR-15a inhibition [30]. The
CREBBP construct showed ,32% mean reduction at 50 nM,
although this reduction is not significant as assessed by p-value.
The sixth mRNA construct, for DVL2, showed . 40% mean
reduction with small variance at 10 nM (p,0.467), but an
increased expression at 50 nM (Figure 8B).
Table 5. Total numbers of predicted targets and signal-to-noise (S:N) ratios among human (RefSeq) mRNAs for the 181 human
miRNAs with an ortholog in mouse, with and without requiring that the orthologous mouse miRNA have a target (under the same
second-stage criterion) in the orthologous mouse mRNA.
Control set Condition
Number of
targets S:N ratio Fold change
MS WC bp (in human) 268375 1.50 (1.00)
WC bp with match in orthologous mouse mRNA 74232 1.87 +0.25
WC bp, no match in orthologous mouse mRNA 194143 1.40 20.07
WC bp and 40% FE threshold (in human) 116117 1.81 (1.00)
WC bp and 40% FE threshold, with match in orthologous mouse mRNA 21574 2.97 +0.64
WC bp and with 40% FE threshold, no match in orthologous mouse mRNA 94543 1.66 20.08
FOM WC bp (in human) 268375 1.21 (1.00)
WC bp with match in orthologous mouse mRNA 74232 1.81 +0.50
WC bp, no match in orthologous mouse mRNA 194143 1.08 20.11
WC bp, ,6 mismatches and GU pairs at nt $15 and 40% FE threshold (in human) 116117 1.34 (1.00)
WC bp, ,6 mismatches and GU pairs at nt $15 and 40% FE threshold, with match
in orthologous mouse mRNA
21574 2.61 +0.95
WC bp, ,6 mismatches and GU pairs at nt $15 and with 40% FE threshold,
no match in orthologous mouse mRNA
94543 1.21 20.10
Lewis WC bp (in human) 112797 1.15 (1.00)
WC bp with match in orthologous mouse mRNA 28456 1.69 +0.47
WC bp, no match in orthologous mouse mRNA 84341 1.04 20.10
WC bp, ,6 mismatches and GU pairs at nt $15 and 40% FE threshold (in human) 46469 1.44 (1.00)
WC bp, ,6 mismatches and GU pairs at nt $15 and 40% FE threshold, with
match in orthologous mouse mRNA
8684 2.66 +0.85
WC bp, ,6 mismatches and GU pairs at nt $15 and with 40% FE threshold,
no match in orthologous mouse mRNA
37785 1.30 20.10
Watson-Crick base pairs (WC bp) are at nucleotide positions 2–7 in every case. MS, mononucleotide shuffle; FOM, first-order Markov process; Lewis, control sequences
from Lewis et al. [2] but based on only 74 miRNAs.
doi:10.1371/journal.pone.0005745.t005
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BCL2, hsa-miR-17-5p/TNFSF12, hsa-miR-324-3p/CREBBP
and hsa-miR-324-3p/WNT9B) exhibit perfect WC complemen-
tarity in the seed regions, while has-miR-324-3p/DVL2 has one
GU pair in the same region (Supplementary Figure S1). Although
the binding site of hsa-miR-324-3p/DVL2 has very low (stable)
free energy, the presence of a GU pair in the seed region means
that binding at the 39 end of the miRNA would have to be optimal
to compensate (if indeed 39-end hybridization can compensate at
all); in this case, however, two unpaired bases and two GU pairs




Computational prediction may be motivated by different aims,
e.g. to annotate sequences, to guide experimental validation, or to
describe a potential solution space. Common to these is the goal of
generating a ranked list of candidates that contains most (ideally
all) true interactions and excludes most (ideally all) non-
interactions. Biological relevance may, however, be contingent
on features other than those being maximized or minimized.
Animal miRNAs, for example, often bind to mRNAs with
suboptimal complementarity as assessed by string-matching [1]
Table 6. For three miRNAs, our predictions (condition: perfect Watson-Crick complementarity at nt 2–7) on targets experimentally
validated by Miranda et al. [9].
miRNA Condition Number of targets
miR-134 WC bp at nt 2–7 True positives 43 Sensitivity=0.551




WC bp at nt 2–7, and 40% FE threshold (218.64) True positives 36 Sensitivity=0.462




miR-296 WC bp at nt 2–7 True positives 8 Sensitivity=0.80




WC bp at nt 2–7, and 40% FE threshold (219.44) True positives 7 Sensitivity=0.70




miR-375 WC bp at nt 2–7 True positives 9 Sensitivity=0.375




WC bp at nt 2–7, and 40% FE threshold (216.68) True positives 8 Sensitivity=0.333




Of 158 genes experimentally tested for regulation by miR-134, 85 occur in our database, as do 14 of 24 tested for regulation by miR-296, and 22 of 44 testedf o r
regulation by miR-375. As Miranda et al. set different criteria for target prediction (e.g. allowing GU pairs and a mismatch in the seed regions) and selected sites for
validation on that basis, not all of their validated sites could have been discovered by our approach. To correct (to the extent possible) for this difference, we excluded a
further 20 target sites with GU pairs and mismatches in the seed region for miR-134, and 8 target sites for miR-296 (all target sites for miR-375 have WC matches in the
seed region), and report the results of 65 target genes examined for miR-134, 6 for miR-296 (for miR-296, all six sites examined were validated), and 22 for miR-375.
Miranda et al. also give details of predicted sites that failed validation (i.e. were false positive predictions); in principle this makes it possible for us to calculate the
specificity of our approach. In some cases, our 40% free energy threshold is more-stringent than that of Miranda et al.( ,216.4 kcal/mol), reducing the sensitivity
calculated for our approach. As the number of false positives is small, specificity values should be interpreted as indicative only.
doi:10.1371/journal.pone.0005745.t006
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PLoS ONE | www.plosone.org 16 May 2009 | Volume 4 | Issue 5 | e5745Figure 8. Experimental validation of predicted target sites. Y-axis: relative luciferase activity (see Methods). (A) has-miR-15a on TSPYL2 and
BCL2; (B) has-miR-324-3p on CREBBP, DBL2 and WNT9B; and (C) has-miR-17-5p on TNFSF12.
doi:10.1371/journal.pone.0005745.g008
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within double-stranded regions, single-stranded loops, and bulges
that are imperfectly represented as strings but nonetheless
contribute to duplex stability. Other features, e.g. post-translational
editing of miRNAs and spatiotemporal co-location within the cell,
may be even more-difficult to represent, or be unknown.
Here we present a scalable approach and software for predicting
miRNA-mRNA interactions and interaction sites, based on
minimizing the free energy of duplex structure. Our method finds
and can report not only the energetically optimal duplex, but also
arbitrarily many energetically suboptimal structures, in genome-
scale data. In the specific context at hand, for each miRNA we
initially identify a large set of candidate sites, and subsequently
remove those that fail to meet additional criteria that reflect
biologically relevant parameters of known or inferred miRNA-
mRNA interactions. In other contexts, the FASTH software might
better be paired with machine-learning or other technologies, e.g.
to assess the relative contributions of specified parameters.
Short regions perfectly complementary to mRNA targets
are preferentially found in the 59 end of miRNAs
In many validated miRNA-mRNA interactions, regions of 6–7
contiguous nucleotides having (near-)perfect WC complementarity
to the mRNA target occur at the 59 end of the miRNA. Our results
confirm this observation, and extend it to energetically favorable
potential target sites not only for validated interactions but more
broadly. Sequence motifs complementary to the 59 end of
miRNAs are preferentially distributed in mRNAs, compared to
motifs that are complementary to the 39 end.
Energetically favorable binding sites are not restricted to
39UTRs
Miranda et al. predicted that a significant number of targets
occur in 59UTRs and CDS and hypothesized that many are
functional, although they could not estimate a false positive rate of
prediction [9]. We likewise find many high-quality binding sites in
all mRNA regions (59UTR, CDS and 39UTR), with the number of
sites and S:N ratio of prediction stable over the range of filtering
parameters examined. For the human and mouse transcriptomes,
target abundance roughly matches availability (length of mRNA
regions). As false-positive as well as true-positive target sites in
higher-GC regions tend to have lower (more-favorable) energies
(above), additional filtering or weighting may be required to
predict target sites in these regions.
Binding sites are often reassigned or lost in alternative
transcript isoforms
At least in mouse [31] and human [32], most protein-coding
genes are transcribed in different isoforms. Here we report that
among isoform sets of multi-transcript human genes, almost 10%
of predicted miRNA target sites are situated in one mRNA region
in one isoform but in a different region in another isoform, i.e.
reassigned between isoforms, as the result of differential splicing.
Within those transcript isoform sets having exactly two isoforms,
the frequency of such reassignment is some 76% (6.0%/3.4%)
greater than expected under a simple transcript length-propor-
tional model. In almost all such cases, reassignment is observed
between the 59UTR and CDS, or between the CDS and 39UTR.
We also find that more than 20% of our predicted miRNA target
sites are present in some but not all isoforms that arise from the
same transcriptional region. As many more mRNA isoforms exist
than are represented in existing databases, the instances of miRNA
binding site reassignment or gain/loss that we predict here almost
certainly under-represent the true number in human (and, by
extension, other complex animals) that arise as a consequence of
transcriptional complexity.
Implication for transcriptional regulation
Some investigations have tried to capture the intersection of
miRNA and transcriptional regulation. For example, Stark et al.
reported that in Drosophila, miRNAs and genes encoding predicted
miRNA targets are expressed in a largely mutually exclusive
manner, and that many genes for basic cellular processes have short
39UTRs and thereby avoid miRNA regulation [33]. Farh et al.
reported that mRNAs expressed in the same tissue as miRNAs are
selectively depleted in sites that match these miRNAs [34].
Our results show that high-quality potential miRNA binding sites
exist in all regions of mRNAs. Indeed, in a complex transcriptional
program such as that of human or mouse, there is some ambiguity
inassigninga target site toa specificmRNAregion;asshown above,
potential target sites are frequently reassigned among mRNA
regions, or indeed lost or gained entirely, in alternative transcript
isoforms, opening the possibility that miRNAs can mediate
transcript-specific regulation, e.g. in different cell types, tissues or
developmental conditions. The observed frequency of site involve-
ment in gain/loss (22.4% of predicted sites) appears somewhat
greater than expected under a simple length-proportional model (a
maximum of 18.5% of nucleotides are similarly gained/lost, based
on the shorter transcript in pairwise comparisons); further analysis is
required to determine whether this difference is real, and if so
whether it might reflect positive selection in these transcriptional
regions or a subset thereof. For one of the experimentally validated
miRNAs in this study, miR-17-5p, we predicted target sites in both
known transcript isoforms of TNFSF12, but in the CDS of one and
the 39UTR of the other.
Most predicted miRNA targets in human and mouse
have no counterpart in the orthologous mRNA of the
other species
Predicted miRNA targets in human mRNAs that have
orthologs in mouse show a higher S:N ratio than do targets in
human mRNAs that lack mouse orthologs. Of these predicted
sites, most (83–87%) occur in the same mRNA region in both
species, i.e. most miRNA targets in orthologous mRNAs are in this
sense themselves orthologous. However, limiting our analysis to
mRNAs with orthologs in the other species diminishes the number
of predicted sites by 72–81%: most potential miRNA target sites
found by searching only human have no counterpart in an
orthologous mouse mRNA (and vice-versa), implying that many
miRNA-mRNA interactions are potentially taxon-specific. Similar
or greater ratios of genome-specific to evolutionarily conserved
potential target sites have been inferred by others [34].
Experimental validation of miRNA-mRNA interaction
We selected, for experimental validation, six miRNA-mRNA
interactions predicted by our method, including one previously
validated interaction [29] and another identified as a possibility
[14]. Using a luciferase assay in HEK293 cells, we showed that
four of these six transcripts are bound by endogenous miRNAs,
with the corresponding mRNA level reduced by an average of
73% (range 59.6%–86.2%) when assayed at 50 nM miRNA.
These four include the previously validated interaction, plus three
of the five (60%) newly predicted interactions for which the
mRNA level was reduced by an average of 77.5% (range 65.4%–
86.2%) when assayed at 50 nM miRNA. A fifth construct showed
a ,32% mean reduction, which could be biologically (function-
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the p-value criterion.
Regardless of where the predicted target site is located in the
mRNA, in our experimental protocol the (synthetic) site was
inserted into the construct so it could be expressed from the
39UTR of luciferase mRNA. Thus we can validate that a target
site is bound by endogenous miRNA and that the mRNA level is
reduced as a consequence, but we do not specifically validate
interaction with the site in its original location or native folded
environment. Duplex formation is prerequisite to biological
function, but these assays examine only the effect of binding on
mRNA level, not its functional consequences.
Conclusions
It has been an open question whether low (strong) energy of the
miRNA-mRNA duplex can serve as a good indicator of miRNA
targets. We have developed and implemented an energy-based
computational approach to miRNA target prediction, applied it to
a standard set of known human mRNA sequences at whole-
transcriptome scale, and experimentally measured the change in
mRNA level for a small number of selected predictions. We
showed that short (6–7 nt) sequence motifs matching mRNAs with
perfect WC complementarity occur more frequently in the 59 end
of miRNAs than in the 39 end, and that high-quality binding sites
are present in all regions of mRNA (59UTR, CDS and 39UTR) in
both human and mouse. We also present evidence that many
high-quality potential miRNA binding sites become located in
different mRNA regions, or are gained or lost altogether,
depending on transcript isoform. These observations open the
possibility that further complexity of genetic regulation arises at
the interface among miRNAs, expression and alternative splicing
in morphologically complex animals. Future directions include
incorporating predicted mRNA structure at the target site,
miRNA and mRNA expression levels, and correlations with
protein expression and phenotype.
Materials and Methods
Data
313 mature human and 233 mature mouse miRNA sequences
were obtained from miRBase release 7.0 [35] (www.sanger.ac.uk/
software/Rfam) and are available as Supplementary Table S8.
mRNA and gene data were obtained from hgdownload.cse.ucs-
c.edu/downloads.html (file mrnaRefseq.txt) and represent 22947
unique mRNAs and 17751 protein-coding genes in human, and
17510 and 16627 in mouse. mRNAs were mapped to gene
identifiers using the files refFlat and refLink also from UCSC, and
coordinates of miRNA genes and miRNA targets were assigned
based on the NCBI Human (hg17, Build 35) and Mouse (mm6,
Build 34) Genome Sequencing Consortium genome builds.
Relative sizes of mRNA regions (59UTR, CDS and 39UTR) were
calculated using annotations in the files rna.gbff downloaded from
NCBI (ftp.ncbi.nih.gov/refseq).
Computational approach
We implemented a two-stage prediction process. First we used
FASTH to search for potential targets in the mRNAs by duplex free
energy, and to rank the results by energy. Then in a second stage we
remove (filter) results that fail to meet further criteria not expressed in
terms of energy score per se, e.g. the minimum number of contiguous
Watson-Crick base pairs in the so-called seed region, or the
maximum number of unpaired bases, bulges and GU pairs. This
second-stage filtering was implemented outside FASTH via Perl
scripts. Detailed descriptions of our computational approach,
including FASTH, are presented in Supplementary Text. Our
target-site predictions with selected parameters in human and mouse
are available as Supplementary Table S9, Supplementary Table S10,
Supplementary Table S11, and Supplementary Table S12.
Statistical description of results
To estimate the false positive rate of prediction we calculate a
signal-to-noise (S:N) ratio, dividing the number of target sites
predicted using known (empirical) miRNAs by the mean number
predictedusingcontrols.Ourmotivationforgeneratingthesecontrols
by two different approaches, mononucleotide shuffling (MS) and a
first-order Markov process (FOM), is presented in the Supplementary
Text. For each known miRNA, the MS control set was constructed
by random permutation, without replacement, of its nucleotides,
preserving both length and nucleotide composition (but not
dinucleotide frequencies, except by chance). The FOM control set,
generated using Sean Eddy’s ‘shuffle’ program in the Squid package
(http://selab.janelia.org/software.html), preserves length and dinu-
cleotide frequencies (but not mononucleotide count, except by
chance).Foreach miRNA we generated 10 MS and 10 FOM control
sequences. In all, 26 3130 control sequences were generated for
human, and 262330 for mouse. These control sequences were then
used to search against the target database under the same second-
stage filtering conditions as for the real miRNA. Results are presented
in Table 5 and Supplementary Table S1.
We additionally used, as a further set of controls, the shuffled
sequences generated by Lewis et al. so as to preserve the expected
frequency of random matching between miRNA seed sequences
and complementary 39UTR sequences [11]. Results are presented
in Table 5 and Supplementary Table S2.
Sensitivity is calculated as true positives/(true positives + false
negatives), and specificity as true negatives/(true negatives + false
positives).
Mapping target locations to regions of mRNAs
Numbers of predicted targets located in the three regions of
mRNAs (59UTR, CDS and 39UTR) were determined by
retrieving sizes (lengths measured by number of nucleotides nt)
of each region in each mRNA from the rna.gbff files for human
and mouse (above), and mapping target sites to these regions using
the coordinates provided.
Modelling the expected frequencies of site reassignment
and gain/loss among isoforms
Genomic coordinates of the first and last nucleotides for each
transcript region (59UTR, CDS, 39UTR, introns if any) in human
were obtained from the refFlat file downloaded from UCSC
(hgdownload.cse.ucsc.edu/downloads.html). The number of nucle-
otides in each mRNA was computed from these coordinates. For
transcriptional regions (genes) with exactly two known isoforms in
this file, comparison is straightforward. For genes with $3 isoforms,
we made all pairwise comparisons, i.e. a gene with four isoforms
requires 4*(421)/2=6 pairwise comparisons. To simplify calcula-
tion we set transcript length (including introns) equal to that of the
longest transcript, so the total number of nucleotides shown in the
Intron/Intron cells is slightly exaggerated (because missing
nucleotides in the shorter transcripts are counted as introns);
otherwise the computation proceeded as for binary transcript sets.
In summarising results (Supplementary Table S3), pairwise
comparisons relative to the longer member of each mRNA pair
were grouped, as were comparisons relative to the shorter member
of each pair. Corresponding calculations were also made correcting
for edge effects (disregarding predicted miRNA target sites that
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region); see Supplementary Table S3 for details.
miRNA target sites with orthologs in mouse
Most of the 233 miRNAs known in mouse have counterparts
extremely similar in sequence (i.e. putative orthologs) among the
313 miRNAs known for human. From among these we extracted
the 181 pairs that have identical sequences at positions 1–8
inclusive (Supplementary Table S13). The sequence of each
human miRNA was randomized, and the S:N ratio calculated, as
described above. Given the computational complexity of the target
search, we used the same sets of random sequences to search both
human and mouse mRNA databases.
Ortholog pairs between the human and mouse mRNA sets were
identified using BioMart (www.biomart.org). A miRNA target site
(e.g. in human) is considered to have an ortholog in the other
species (e.g. mouse) if the miRNAs and targeted mRNAs are
orthologs in the two species. For example, the human miRNA has-
miR-378 is predicted to have a target site in the mRNA
corresponding to human gene BCL7A, while mmu-miR-378, the
mouse ortholog of has-miR-378, has a target site in the mRNA for
Bcl7a (the orthologous gene in mouse). We thus consider the has-
miR-378 target site in BCL7A to have an ortholog in mouse, and
infer that regulation of these genes by this miRNA has been
evolutionarily conserved between human and mouse.
GO terms
GO terms were retrieved and analysed using DAVID [36].
Experimental validation
To determine the effect of each miRNA on its predicted targets,
synthetic oligonucleotides corresponding to 60 nt around the
target sequence were cloned into the SpeI and HindIII sites of
pMIR-REPORT Luciferase (Ambion). All constructs were verified
by sequencing. HEK293 cells were maintained in DMEM
(GibcoBRL) containing 10% (v/v) foetal calf serum in a 5%
CO2 atmosphere at 37uC. Cells were transfected using Effectene
(Qiagen) according to manufacturer’s instructions. In each well,
5610
4 cells were co-transfected with 100 ng of a pMIR-REPORT
Luciferase construct, 100 ng of pMIR-REPORT b-galactosidase
(Ambion), and either 10 or 50 nM of the appropriate pre-miR
miRNA precursor (Ambion). After transfection, cells were
incubated for 42 hours prior to harvesting.
Luciferase activity was measured in the presence of either the
test miRNA or a control miRNA. p-values were derived using
Student’s t-test on the mean and standard deviations of the
normalized luciferase signal of test miRNAs, and on the negative
control miRNAs for the same reporter construct. Before
averaging, luciferase activity was normalized to the corresponding
signal from the b-galactosidase reporter. Luciferase activity was
assayed using the Luciferase Assay System (Promega) and detected
on a Wallac 1420 luminometer (Perkin Elmer). b-galactosidase
activity was determined using the b-Galactosidase Enzyme Assay
System (Promega) and detected on a PowerWave XS spectropho-
tometer (BioTek). Each assay was repeated at least three times.
Predicted mRNA targets were selected for experimental
validation based on our groups’ ongoing interest in cancer and
in Wnt signalling, as described further in the text.
Availability
The FASTH source code is available by request from MZ
(zukerm@rpi.edu). It is configured to run in a Unix or Linux
environment.
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